Keiko Nozaki-Kanno
Fukushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Partial central diabetes insipidus during lithium use: A case report and literature review.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: March 17, 2025
Predictive Validity of the 5-Factor PANSS Model in Acute Schizophrenia: Early Response to Aripiprazole and Brexpiprazole.
Journal: Journal of clinical psychopharmacology
Published: January 22, 2025
Real-world Effectiveness and Tolerability of Lurasidone in Outpatients with Bipolar DisorderII- A 24 week retrospective study (RETLO-BDIIstudy).
Journal: Journal of affective disorders
Published: December 26, 2024
Factors associated with cognitive dysfunction in treatment-responsive and -resistant schizophrenia: A pilot cross-sectional study.
Journal: Journal of psychiatric research
Published: April 26, 2024
Clozapine-Associated Myocarditis in a Patient With Schizophrenia Taking Lemborexant: A Case Report.
Journal: Journal of clinical psychopharmacology
Published: February 08, 2024
Switching to lemborexant for the management of insomnia in mental disorders: the SLIM study.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: May 27, 2023
Effect of lemborexant on pharmacokinetics of clozapine: A potential drug-drug interaction mediated by time-dependent inhibition of CYP3A4.
Journal: British journal of clinical pharmacology
Published: April 19, 2023
Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder.
Journal: Neuropsychiatric disease and treatment
Published: February 14, 2021
Plasma levels of dopamine metabolite correlate with mismatch negativity in patients with schizophrenia.
Journal: Psychiatry and clinical neurosciences
Published: July 19, 2019
Low- and high-dose aripiprazole augmentation and plasma levels of homovanillic acid in major depressive disorder: A randomized, open-label study.
Journal: Human psychopharmacology
Published: March 13, 2019
COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: June 29, 2018
The Relationship between Mismatch Negativity and the COMTVal108/158Met Genotype in Schizophrenia.
Journal: Neuropsychobiology
Published: May 30, 2018
Last Updated: 09/26/2026